Bots Portfolio News Brokers Calendar Rankings AI Analysis

🔍

Loading...

ZivFin

A global finance community where investors connect without language barriers.

Services

Stocks ETF Crypto Forex Rankings

Company

About FAQ Contact Partnership Brokers

Legal

Terms Privacy Cookie Settings

⚠️ All information on ZivFin is not investment advice. Stock data is delayed by 15 minutes. Investment decisions are your own responsibility.© 2026 ZivFin. All rights reserved.

About Contact FAQ Terms Privacy Cookie Settings

⚠️ All information on ZivFin is not investment advice. Stock data is delayed by 15 minutes. Investment decisions are your own responsibility.

© 2026 ZivFin. All rights reserved.

Home Community Bots Portfolio

When Leverage Goes Wrong on Wall Street | ZivFin News | ZivFin

← Back to News

Home/News/When Leverage Goes Wrong on Wall Street

Market

When Leverage Goes Wrong on Wall Street

Yahoo2026.08.08Source: Yahoo

When Leverage Goes Wrong on Wall Street

Hedge fund Situational Awareness is forced to sell its equity holdings, leading to a drop and a pop in AI-related stocks. What went wrong?

← Back to News

RelatedTSLA...-

Was this article helpful?

Community

Loading comments...

Next Article

Bitcoin’s BIP-110 enters mandatory signaling with miner support below 3%

Cointelegraph2026.08.08

Bitcoin’s BIP-110 enters mandatory signaling with miner support below 3%

The deployment milestone tests whether enforcing nodes can sustain the change amid limited miner signaling and discussion of a hard-fork fallback.

More News

Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed?

Yahoo2026.08.08

Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI Adoption - Has The Bull Case Changed?

Doximity, Inc. recently reported fiscal first-quarter 2027 results, with revenue rising to US$156.62 million from US$145.91 million a year earlier, while net income and earnings per share declined year on year. Management emphasized rapid uptake and monetization of its clinical AI tools, updating guidance to US$170–171 million for second-quarter revenue and US$671–681 million for full-year revenue. We’ll now examine how Doximity’s raised revenue outlook, underpinned by accelerating adoption...

More News

NiSource Q2 Earnings Call Highlights

Yahoo2026.08.08

NiSource Q2 Earnings Call Highlights

NiSource (NYSE:NI) reported second-quarter 2026 adjusted earnings of $0.16 per share, compared with $0.22 per share a year earlier, while reaffirming its full-year earnings outlook and long-term growth targets. Year-to-date adjusted earnings rose to $1.22 per share, up $0.03 from the same period in